August 15, 2025Arteriosclerosis Thrombosis and Vascular Biology

Spleen Tyrosine Kinase Inhibition Mitigates Hemin-Induced Thromboinflammation in an Organ-Specific Manner in Sickle Cell Mice

View Full Paper

Ask AI

Bookmark

Authors

JEJuma El-AwaisiUniversity of Birmingham GPGina PerrellaUniversity College Birmingham NMNicolas MayorUniversity of Birmingham

Discussion

Member takes

Implication

Inhibition of spleen tyrosine kinase improves blood perfusion and reduces thromboinflammation in sickle cell disease, suggesting potential therapeutic options.

Key Points

Spleen tyrosine kinase inhibition effectively restores blood perfusion and reduces thromboinflammation in SCD mice, enhancing vascular health.
In vivo experiments show that low-dose Syk inhibition reduced neutrophil adhesion and improved renal and pulmonary perfusion without causing bleeding.
Advanced imaging techniques revealed organ-specific mechanisms behind hemin-induced hypoperfusion and cell adhesion in SCD, focusing on the kidney and lung.
The findings indicate that targeted Syk inhibition could be a viable treatment strategy for managing VOC and related complications in sickle cell disease.

Cite This Study

El-Awaisi et al. (2025) studied this question.

synapsesocial.com/papers/68af2d6fcf1dd9ea359e5028 https://doi.org/10.1161/atvbaha.124.322072

View Full Paper

Ask AI

Bookmark

Implication

Inhibition of spleen tyrosine kinase improves blood perfusion and reduces thromboinflammation in sickle cell disease, suggesting potential therapeutic options.

Spleen Tyrosine Kinase Inhibition Mitigates Hemin-Induced Thromboinflammation in an Organ-Specific Manner in Sickle Cell Mice

Discussion

Member takes

Implication

Key Points

Cite This Study

Spleen Tyrosine Kinase Inhibition Mitigates Hemin-Induced Thromboinflammation in an Organ-Specific Manner in Sickle Cell Mice

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider